Hanna, John Gordon

Insider profile

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 65% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Hanna, John Gordon's trades of HLS Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
346.04
Quantity 85,477 +44.2%
Value CA$580,531
Transaction date
Purchase
Price
267.03
Quantity 7,006 +18.3%
Value CA$3,980,944
Transaction date
Purchase
Price
324.37
Quantity 55,130 +41.4%
Value CA$1,982,280
Transaction date
Purchase
Price
4.50
Quantity 4,000
Value CA$18,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-17 2026-06-16 B Purchase
85,477 +44.2%
346.04
CA$580,531
85,477 +44.2% 346.04 CA$580,531
2024-08-14 2024-08-14 B Purchase
7,006 +18.3%
267.03
CA$3,980,944
7,006 +18.3% 267.03 CA$3,980,944
2024-08-14 2024-08-13 B Purchase
55,130 +41.4%
324.37
CA$1,982,280
55,130 +41.4% 324.37 CA$1,982,280
2023-08-29 2023-08-25 B Purchase
4,000
4.50
CA$18,000
4,000 4.50 CA$18,000